Cargando…

Biomimetic nanoparticles to enhance the reverse cholesterol transport for selectively inhibiting development into foam cell in atherosclerosis

A disorder of cholesterol homeostasis is one of the main initiating factors in the progression of atherosclerosis (AS). Metabolism and removal of excess cholesterol facilitates the prevention of foam cell formation. However, the failure of treatment with drugs (e.g. methotrexate, MTX) to effectively...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Li, Li, Hongjiao, Li, Jiyu, Zhong, Yuan, Wu, Shuai, Yan, Meng, Ni, Sheng, Zhang, Kun, Wang, Guixue, Qu, Kai, Yang, Deqin, Qin, Xian, Wu, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463892/ https://www.ncbi.nlm.nih.gov/pubmed/37644442 http://dx.doi.org/10.1186/s12951-023-02040-9

Ejemplares similares

Macrophage membrane functionalized biomimetic nanoparticles for targeted anti-atherosclerosis applications
por: Wang, Yi, et al.
Publicado: (2021)

Effects of Astaxanthin on Reverse Cholesterol Transport and Atherosclerosis in Mice
por: Zou, Tang-Bin, et al.
Publicado: (2017)

ROS-responsive biomimetic nanoparticles for potential application in targeted anti-atherosclerosis
por: Tang, Dan, et al.
Publicado: (2021)

Cell membrane camouflaged biomimetic nanoparticles: Focusing on tumor theranostics
por: Zhu, Li, et al.
Publicado: (2022)

Caveolae and Caveolin-1 Integrate Reverse Cholesterol Transport and Inflammation in Atherosclerosis
por: Qin, Li, et al.
Publicado: (2016)

Crocin ameliorates atherosclerosis by promoting the reverse cholesterol transport and inhibiting the foam cell formation via regulating PPARγ/LXR-α
por: Zhang, Feng, et al.
Publicado: (2022)

Novel technique for generating macrophage foam cells for in vitro reverse cholesterol transport studies
por: Sengupta, Bhaswati, et al.
Publicado: (2013)

Biomimetic Nanotherapies: Red Blood Cell Based Core–Shell Structured Nanocomplexes for Atherosclerosis Management
por: Wang, Yi, et al.
Publicado: (2019)

Sulforaphane Inhibits Foam Cell Formation and Atherosclerosis via Mechanisms Involving the Modulation of Macrophage Cholesterol Transport and the Related Phenotype
por: Liu, Shiyan, et al.
Publicado: (2023)

The Liver-Selective Thyromimetic T-0681 Influences Reverse Cholesterol Transport and Atherosclerosis Development in Mice
por: Tancevski, Ivan, et al.
Publicado: (2010)

Gasdermin D Mediates Inflammation-Induced Defects in Reverse Cholesterol Transport and Promotes Atherosclerosis
por: Opoku, Emmanuel, et al.
Publicado: (2021)

The Role of Macrophage Lipophagy in Reverse Cholesterol Transport
por: Jeong, Se-Jin, et al.
Publicado: (2017)

Is reverse cholesterol transport regulated by active cholesterol?
por: Steck, Theodore L., et al.
Publicado: (2023)

Tachometer for Reverse Cholesterol Transport?
por: Eckardstein, Arnold
Publicado: (2012)

Cell-derived biomimetic nanoparticles as a novel drug delivery system for atherosclerosis: predecessors and perspectives
por: Yang, Long, et al.
Publicado: (2020)

NAMPT knockdown attenuates atherosclerosis and promotes reverse cholesterol transport in ApoE KO mice with high-fat-induced insulin resistance
por: Li, Shengbing, et al.
Publicado: (2016)

Apoprotein E and Reverse Cholesterol Transport
por: Getz, Godfrey S., et al.
Publicado: (2018)

Myricetin ameliorates atherosclerosis in the low-density-lipoprotein receptor knockout mice by suppression of cholesterol accumulation in macrophage foam cells
por: Meng, Zhe, et al.
Publicado: (2019)

FURTHER STUDIES ON THE REVERSIBILITY OF SERUM SICKNESS CHOLESTEROL-INDUCED ATHEROSCLEROSIS
por: Van Winkle, M., et al.
Publicado: (1970)

Reverse Cholesterol Transport Pathway and Cholesterol Efflux in Diabetic Retinopathy
por: Zhang, Xinyuan, et al.
Publicado: (2021)

Biomimetic Antigravity Water Transport and Remote Harvesting Powered by Sunlight
por: Geng, Hongya, et al.
Publicado: (2020)

RGD peptide modified RBC membrane functionalized biomimetic nanoparticles for thrombolytic therapy
por: Xu, Zichen, et al.
Publicado: (2023)

Synergistic treatment of osteosarcoma with biomimetic nanoparticles transporting doxorubicin and siRNA
por: Zhao, Jingtong, et al.
Publicado: (2023)

Pro-efferocytic macrophage membrane biomimetic nanoparticles for the synergistic treatment of atherosclerosis via competition effect
por: Sha, Xuan, et al.
Publicado: (2022)

Inflammatory endothelium-targeted and cathepsin responsive nanoparticles are effective against atherosclerosis
por: Fang, Fei, et al.
Publicado: (2022)

The Regulation of Reverse Cholesterol Transport and Cellular Cholesterol Homeostasis by MicroRNAs
por: DiMarco, Diana M., et al.
Publicado: (2015)

Biomimetic nanomedicines for precise atherosclerosis theranostics
por: Tao, Ying, et al.
Publicado: (2023)

Investigation of the Effect of Nanoparticle-Stabilized Foam on EOR: Nitrogen Foam and Methane Foam
por: Xu, Zhengxiao, et al.
Publicado: (2020)

CLI-095 decreases atherosclerosis by modulating foam cell formation in apolipoprotein E-deficient mice
por: WANG, XIAO-QING, et al.
Publicado: (2016)

Treatment of atherosclerosis by macrophage-biomimetic nanoparticles via targeted pharmacotherapy and sequestration of proinflammatory cytokines
por: Gao, Cheng, et al.
Publicado: (2020)

Scavenger receptor class B member 1 protein: hepatic regulation and its effects on lipids, reverse cholesterol transport, and atherosclerosis
por: Kent, Anthony P, et al.
Publicado: (2011)

An Apolipoprotein A-I Mimetic Peptide Designed with a Reductionist Approach Stimulates Reverse Cholesterol Transport and Reduces Atherosclerosis in Mice
por: Ditiatkovski, Michael, et al.
Publicado: (2013)

Macrophage Foam Cell-Targeting Immunization Attenuates Atherosclerosis
por: Wang, Fazhan, et al.
Publicado: (2019)

Role of Phospholipid Transfer Protein in High-Density Lipoprotein– Mediated Reverse Cholesterol Transport
por: Yazdanyar, Amirfarbod, et al.
Publicado: (2011)

Biomimetic nanoparticles for tumor immunotherapy
por: Yu, Hanqing, et al.
Publicado: (2022)

Disruption of USP9X in macrophages promotes foam cell formation and atherosclerosis
por: Wang, Biqing, et al.
Publicado: (2022)

Canagliflozin Facilitates Reverse Cholesterol Transport Through Activation of AMPK/ABC Transporter Pathway
por: Zhao, Yingnan, et al.
Publicado: (2021)

Neuropeptide Y regulates cholesterol uptake and efflux in macrophages and promotes foam cell formation
por: Cai, Yu, et al.
Publicado: (2022)

E17110 promotes reverse cholesterol transport with liver X receptor β agonist activity in vitro
por: Li, Ni, et al.
Publicado: (2016)

Emerging role of lymphatic vessels in reverse cholesterol transport
por: Veronique, Angeli, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_a5r4107j2h8mlslplhka3bok2r